Evaluation of Fluoxetine for Refractory Constipation With Somatic Symptom Disorder Features

Clinical trial NCT06506136 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06506136
Sponsor: Zhifeng Zhao, PhD
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Refractory Constipation Somatic Symptom Disorder (DSM-5)Functional Constipation (FC)

Start date: 2025-09-01
Primary completion: 2026-06-01
Enrollment: 194

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.